Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 413

2.

Anti-mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice.

Masaki H, Appel MC, Leahy L, Leif J, Paquin L, Shultz LD, Mordes JP, Greiner DL, Rossini AA.

Xenotransplantation. 2006 May;13(3):224-32.

PMID:
16756565
3.

NOD mice have a generalized defect in their response to transplantation tolerance induction.

Markees TG, Serreze DV, Phillips NE, Sorli CH, Gordon EJ, Shultz LD, Noelle RJ, Woda BA, Greiner DL, Mordes JP, Rossini AA.

Diabetes. 1999 May;48(5):967-74.

PMID:
10331399
4.

Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.

Molano RD, Berney T, Li H, Cattan P, Pileggi A, Vizzardelli C, Kenyon NS, Ricordi C, Burkly LC, Inverardi L.

Diabetes. 2001 Feb;50(2):270-6.

5.

Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.

Li JM, Gorechlad J, Larsen CP, Waller EK.

Biol Blood Marrow Transplant. 2006 Dec;12(12):1239-49.

6.

Robust tolerance to fully allogeneic islet transplants achieved by chimerism with minimal conditioning.

Luo B, Nanji SA, Schur CD, Pawlick RL, Anderson CC, Shapiro AM.

Transplantation. 2005 Aug 15;80(3):370-7.

PMID:
16082333
7.

Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.

Pan Y, Luo B, Sozen H, Kalscheuer H, Blazar BR, Sutherland DE, Hering BJ, Guo Z.

Transplantation. 2003 Jul 15;76(1):216-24.

PMID:
12865813
8.

Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat.

Itakura S, Asari S, Rawson J, Ito T, Todorov I, Liu CP, Sasaki N, Kandeel F, Mullen Y.

Am J Transplant. 2007 Feb;7(2):336-46.

PMID:
17283484
9.
10.

Viral abrogation of stem cell transplantation tolerance causes graft rejection and host death by different mechanisms.

Forman D, Welsh RM, Markees TG, Woda BA, Mordes JP, Rossini AA, Greiner DL.

J Immunol. 2002 Jun 15;168(12):6047-56.

11.

Tolerance induction through megadose bone marrow transplantation with two-signal blockade.

Lee EN, Lee J, Kim EY, Park HJ, Chang CY, Jung DY, Choi SY, Lee SK, Kwon CH, Joh JW, Kim SJ.

J Surg Res. 2006 Jan;130(1):102-9. Epub 2005 Sep 23.

PMID:
16183077
12.
13.
14.

Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance.

Phillips NE, Markees TG, Mordes JP, Greiner DL, Rossini AA.

J Immunol. 2003 Mar 15;170(6):3015-23.

15.

Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity.

Nikolic B, Takeuchi Y, Leykin I, Fudaba Y, Smith RN, Sykes M.

Diabetes. 2004 Feb;53(2):376-83.

16.

Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice.

Verda L, Kim DA, Ikehara S, Statkute L, Bronesky D, Petrenko Y, Oyama Y, He X, Link C, Vahanian NN, Burt RK.

Stem Cells. 2008 Feb;26(2):381-6. Epub 2007 Nov 1.

17.
20.

Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.

Li H, Kaufman CL, Boggs SS, Johnson PC, Patrene KD, Ildstad ST.

J Immunol. 1996 Jan 1;156(1):380-8.

PMID:
8598488

Supplemental Content

Support Center